Cover Image
市場調查報告書

肺活量計的全球市場分析:企業簡介,市場規模、佔有率、成長率、趨勢、未來預測

Global Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

出版商 Data Bridge Market Research Private Limited 商品編碼 590842
出版日期 內容資訊 英文 350 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
肺活量計的全球市場分析:企業簡介,市場規模、佔有率、成長率、趨勢、未來預測 Global Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
出版日期: 2017年11月01日 內容資訊: 英文 350 Pages
簡介

本報告提供全球肺活量計市場相關分析,市場概況和市場佔有率結構,主要的推動及阻礙市場要素,市場規模趨勢預測 (今後8年份),各產品種類、各技術、各用途、各終端用戶、各流通管道、各地區的詳細趨勢,市場競爭環境,主要企業簡介等調查

第1章 簡介

第2章 市場明細

第3章 市場概要

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 全球肺活量計市場:各產品種類

  • 概要
  • 桌上式肺活量計
  • 可攜式 (手持式) 肺活量計
  • 桌上型電腦(桌面) (PC) 肺活量計

第7章 全球肺活量計市場:各技術

  • 概要
  • 容量檢測型肺活量計 (濕式、乾式)
  • 流量檢測型肺活量計 (呼吸速度記錄系統、質量流量計)
  • PFM (尖峰吐氣流量計)

第8章 全球肺活量計市場:各用途

  • 概要
  • 診斷用
  • 治療用

第9章 全球肺活量計市場:各終端用戶

  • 概要
  • 醫院
  • 診所
  • 家庭治療

第10章 全球肺活量計市場:各流通管道

  • 概要
  • 商店銷售型 (OTC)
  • 直銷、交付型

第11章 全球肺活量計市場:各地區

  • 各國市場詳細趨勢 (各產品種類、各技術、各用途、各終端用戶、各流通管道)
    • 北美 (美國,加拿大,墨西哥)
    • 歐洲 (德國,法國,英國,義大利,西班牙,俄羅斯,土耳其,比利時,荷蘭,瑞士等)
    • 亞太地區 (日本,中國,韓國,印度,澳洲,新加坡,泰國,馬來西亞,印尼,菲律賓等)
    • 南美市場 (巴西等)
    • 中東、非洲市場 (南非等)
  • 主要國家市場詳細分析

第12章 全球肺活量計市場:競爭環境

  • 各企業市場佔有率分析:全球
  • 各企業市場佔有率分析:北美
  • 各企業市場佔有率分析:歐洲
  • 各企業市場佔有率分析:亞太地區
  • 各企業市場佔有率分析:中東、非洲
  • 各企業市場佔有率分析:南美
  • 企業合併、收購 (M&A)
  • 新產品的上市、認證
  • 事業擴張
  • 在法規方面的問題
  • 事業聯盟,其他策略發展情形

第13章 全球肺活量計市場:企業簡介

  • WELCH ALLYN
    • 企業概要
    • 財務分析
    • 產品矩陣
    • 近幾年主要的動向
    • DATABRIDGE分析
  • MIDMARK CORP.
  • FUTUREMED
  • COSMED
  • MGC DIAGNOSTICS CORPORATION
  • 日本光電
  • CAREFUSION CORPORATION
  • MEDICAL INTERNATIONAL RESEARCH
  • VITALOGRAPH
  • NDD MEDICAL TECHNOLOGIES, INC.
  • SCHILLER AG
  • JONES MEDICAL INSTRUMENT COMPANY

第14章 附錄

第15章 關於DATA BRIDGE MARKET RESEARCH

目錄

The Global Spirometer Market is accounted to reach USD 1,041.3 million by 2024 from USD 553.9 million in 2016; it is growing at a CAGR of 8.3%.

The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.

The key market players for Global Spirometer Market are listed below:

BD,

Midmark Corp.

Welch allyn

SDI Diagnostics,

Geratherm Respiratory GMBH,

The market is further segmented into:

Type

Application

End User

Geography

The Global spirometer market is segmented on the basis of product type, technology, disease, disposable components, application, end-user and distribution channel. On the basis of product type, the Global spirometer market is segmented into table-top spirometer, hand-held spirometer and pc based spirometer. In 2017, table-top spirometer is expected to dominate the Global spirometer market with 39.3% market share and is expected to reach USD 404.4 million by 2024, growing a CAGR of 8.2% in the forecast period 2017 to 2024.

Based on technology, the Global spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Global spirometer market with 67.3% market share and is expected to reach USD 719.5 million by 2024, growing at a CAGR of 8.7% in the forecast period 2017 to 2024.

Based on disease, the Global spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Global spirometer market with 40.5% market share and is expected to reach USD 438.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.

Based on disposable components, the Global spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Global spirometer market with 74.0% market share and is expected to reach USD 781.6 million by 2024, growing with the highest CAGR of 8.6% in the forecast period 2017 to 2024.

Based on application, the Global spirometer market is segmented into diagnostics and therapeutic. In 2017, diagnostics is expected to dominate the Global spirometer market with 65.4% market share and is expected to reach USD 707.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.

Based on end-user, the Global spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Global spirometer market with 50.0% market share and is expected to reach USD 537.0 million by 2024, growing at a CAGR of 8.8% in the forecast period 2017 to 2024.

Based on distribution channel, the Global spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Global spirometer market with 64.4% market share and is expected to reach USD 684.0 million by 2024, growing at a CAGR of 8.6% in the forecast period 2017 to 2024.

Based on geography, the Global Spirometer market is segmented into 11 geographical regions, such as,

North America,

South America,

Europe,

APAC,

MEA

Covered in this report

The report covers the present scenario and the growth prospects of the Global Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

INTRODUCTION

  • 1.1. OVERVIEW OF THE GLOBAL SPIROMETER MARKET
  • 1.2. CURRENCY AND PRICING
  • 1.3. LIMITATION
  • 1.4. MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL SPIROMETER MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6 PORTER'S FIVE FORCES MATRIX
    • 2.2.7 PEST ANALYSIS
    • 2.2.8. EPIDEMIOLOGY FORECASTING MODELS
  • 2.3. GLOBAL SPIROMETER MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1. DRIVERS
  • 3.2. RESTRAINTS
  • 3.3. OPPORTUNITIES
  • 3.4. CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL SPIROMETER MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. TABLE-TOP SPIROMETER
  • 6.3. HAND-HELD SPIROMETER
  • 6.4. DESKTOP(PC) SPIROMETER

7 GLOBAL SPIROMETER MARKET, BY TECHNOLOGY

  • 7.1. OVERVIEW
  • 7.2. VOLUME MEASUREMENT SPIROMETER(WET AND DRY)
  • 7.3. FLOW MEASUREMENT SPIROMETER (PNEUMOTACHOGRAPH SYSTEM AND MASS FLOW METER)
  • 7.4. PEAK FLOW METER (PFM)

8 GLOBAL SPIROMETER MARKET, BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. DIAGNOSTIC
  • 8.3. THERAPEUTIC

9 GLOBAL SPIROMETER MARKET, BY END USER

  • 9.1. OVERVIEW
  • 9.2. HOSPITALS
  • 9.3. CLINIC
  • 9.4. HOMECARE

10 GLOBAL SPIROMETER MARKET, BY APPLICATION

  • 10.1. OVERVIEW
  • 10.2. OVER THE COUNTER
  • 10.3. DIRECT TENDER

11 GLOBAL SPIROMETER MARKET, BY GEOGRAPHY

  • 11.1. COUNTRYWISE GLOBAL SPIROMETER MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 11.1.1. NORTH AMERICA
      • 11.1.1.1. U.S.
      • 11.1.1.2. CANADA
      • 11.1.1.3. MEXICO
    • 11.1.2. EUROPE
      • 11.1.2.1. GERMANY
      • 11.1.2.2. FRANCE
      • 11.1.2.3. U.K.
      • 11.1.2.4 ITALY
      • 11.1.2.5 SPAIN
      • 11.1.2.6 RUSSIA
      • 11.1.2.7 TURKEY
      • 11.1.2.8 BELGIUM

11.1.2.9NETHERLANDS

      • 11.1.2.10 SWITZERLAND
      • 11.1.2.11 REST OF EUROPE
    • 11.1.3 ASIA-PACIFIC (APAC)
      • 11.1.3.1 JAPAN
      • 11.1.3.2 CHINA
      • 11.1.3.3 SOUTH KOREA
      • 11.1.3.4 INDIA
      • 11.1.3.5 AUSTRALIA
      • 11.1.3.6 SINGAPORE
      • 11.1.3.7 THAILAND
      • 11.1.3.8 MALAYSIA
      • 11.1.3.9 INDONESIA
      • 11.1.3.10 PHILIPPINES
      • 11.1.3.11 REST OF APAC
    • 11.1.4 LATIN AMERICA
      • 11.1.4.1 BRAZIL
      • 11.1.4.2 REST OF LATIN AMERICA
    • 11.1.5 MIDDLE EAST AND AFRICA
      • 11.1.5.1 SOUTH AFRICA
      • 11.1.5.2 REST OF MIDDLE EAST AND AFRICA
  • 11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12 GLOBAL SPIROMETER MARKET: COMPETITIVE LANDSCAPE

  • 12.1. GLOBAL SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.2. NORTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.3. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.4. APAC SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.5. MEA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.6. SOUTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.7. MERGERS & ACQUISITIONS
  • 12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 12.9. EXPANSIONS
  • 12.10. REGULATORY CHANGES
  • 12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES

13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES

  • 13.1 WELCH ALLYN
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL ANALYSIS
    • 13.1.3 PRODUCT MATRIX
    • 13.1.4 RECENT DEVELOPMENTS
    • 13.1.5 DATABRIDGE ANALYSIS
  • 13.2 MIDMARK CORP.
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL ANALYSIS
    • 13.2.3 PRODUCT MATRIX
    • 13.2.4 RECENT DEVELOPMENTS
    • 13.2.5 DATABRIDGE ANALYSIS
  • 13.3 FUTUREMED
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL ANALYSIS
    • 13.3.3 PRODUCT MATRIX
    • 13.3.4 RECENT DEVELOPMENTS
    • 13.3.5 DATABRIDGE ANALYSIS
  • 13.4 COSMED
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL ANALYSIS
    • 13.4.4 PRODUCT MATRIX
    • 13.4.4 RECENT DEVELOPMENTS
    • 13.4.5 DATABRIDGE ANALYSIS
  • 13.5 MGC DIAGNOSTICS CORPORATION
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL ANALYSIS
    • 13.5.3 PRODUCT MATRIX
    • 13.5.4 RECENT DEVELOPMENTS
    • 13.5.5 DATABRIDGE ANALYSIS
  • 13.6 NIHON KOHDEN CORPORATION
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL ANALYSIS
    • 13.6.3 PRODUCT MATRIX
    • 13.6.4 RECENT DEVELOPMENTS
    • 13.6.5 DATABRIDGE ANALYSIS
  • 13.7 CAREFUSION CORPORATION
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL ANALYSIS
    • 13.7.3 PRODUCT MATRIX
    • 13.7.4 RECENT DEVELOPMENTS
    • 13.7.5 DATABRIDGE ANALYSIS
  • 13.8 MEDICAL INTERNATIONAL RESEARCH
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL ANALYSIS
    • 13.8.3 PRODUCT MATRIX
    • 13.8.4 RECENT DEVELOPMENTS
    • 13.8.5 DATABRIDGE ANALYSIS
  • 13.9 VITALOGRAPH
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL ANALYSIS
    • 13.9.3 PRODUCT MATRIX
    • 13.9.4 RECENT DEVELOPMENTS
    • 13.9.5 DATABRIDGE ANALYSIS
  • 13.10 NDD MEDICAL TECHNOLOGIES, INC.
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL ANALYSIS
    • 13.10.3 PRODUCT MATRIX
    • 13.10.4 RECENT DEVELOPMENTS
    • 13.10.5 DATABRIDGE ANALYSIS
  • 13.11 SCHILLER AG
    • 13.11.1 COMPANY OVERVIEW
    • 13.11.2 FINANCIAL ANALYSIS
    • 13.11.3 PRODUCT MATRIX
    • 13.11.4 RECENT DEVELOPMENTS
    • 13.11.5 DATABRIDGE ANALYSIS
  • 13.12 JONES MEDICAL INSTRUMENT COMPANY
    • 13.12.1 COMPANY OVERVIEW
    • 13.12.2 FINANCIAL ANALYSIS
    • 13.12.3 PRODUCT MATRIX
    • 13.12.4 RECENT DEVELOPMENTS
    • 13.12.5 DATABRIDGE ANALYSIS

14 APPENDIX

15 ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top